Clinical Trial Update: Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies [Phase 1]

View source ↗

Summary

Phase 1 safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed prior therapy has been completed, evaluating safety acro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• liposomal docetaxel (docetaxel liposome formulation)

Snippet

Sponsor: Azaya Therapeutics, Inc. | Conditions: Solid Tumor, Breast Cancer | Phase 1 | Status: COMPLETED